Trending/delta
Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease, Mayo Clinic study finds
ROCHESTER, Minn. — A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of…
December 20, 2021
Reinfection rates of omicron and why people need to take this seriously
August 6, 2021
Special Topics
Sign up
Mayo Clinic Connect
An online patient support community